IDH1 and astrocytoma (excluding glioblastoma): Negative ATRX status was found in only 13.96% of the GBM lot and in 41.67% of the ASTROG4 lot, aligning with the distinct genetic alteration patterns characteristic of IDH-mutant astrocytoma.